Combination of selective androgen and estrogen receptor modulators in orchiectomized rats.
Paul Jonathan RochV WolgastM-M GebhardtK O BökerD B HoffmannD SaulA F SchillingS SehmischM KomrakovaPublished in: Journal of endocrinological investigation (2022)
The OST + RAL treatment appeared to be a promising option in the treatment of androgen-deficient conditions and showed fewer side effects than the respective single treatments.